With its reduced injection frequency, insulin icodec (Awiqli) has the potential to provide better adherence and greater treatment satisfaction in some patients.
When high-risk drinking is identified, one of the first steps is to provide a brief intervention to support positive behaviour change related to alcohol use.
Picture this: you’re filling/verifying prescriptions and you get that all too familiar pop-up that notifies you of a QT-prolongation interaction . . . how should you approach this?